Press Announcements > FDA permits marketing of artificial intelligence-based device to detect certain diabetes-related eye problems

Press Announcements > FDA permits marketing of artificial intelligence-based device to detect certain diabetes-related eye problems



FDA permits marketing of artificial intelligence-based device to detect certain diabetes-related eye problems



The U.S. Food and Drug Administration today permitted marketing of the first medical device to use artificial intelligence to detect greater than a mild level of the eye disease diabetic retinopathy in adults who have diabetes. Continue reading.